Corrigendum to "I-alowCD11bhigh DC Regulates the Immune Response in the Eyes of Experimental Autoimmune Uveitis".

[This corrects the article DOI: 10.1155/2020/6947482.].

In the article titled “I-alowCD11bhigh DC regulates the immune response in the eyes of experimental autoimmune uveitis” [1], affiliation 1 was incorrect and the correct affiliation is shown above. The authors also requested to correct a typographical error in the Methods and Materials section as follows:

“EAU in C57BL/6 mice was inducted by the 350 μg of human interphotoreceptor retinoid-binding protein peptide (IRBP)1-20 (China Peptides Co.,Ltd., Shanghai, China) emulsified in complete Freund's adjuvant with mycobacterium (CFA, Sigma-Aldrich, St. Louis, MO, USA). A total of 500 ng of Pertussis toxin (PTX, Enzo Life Sciences, Farmingdale, YN, USA) was intraperitoneally injected at the footpad, neck, two sides, and tail at six points for every mouse as previously described [35]”

should be corrected as follows:

“EAU in C57BL/6 mice was inducted by the 350 μg of human interphotoreceptor retinoid-binding protein peptide (IRBP)1-20 (China Peptides Co., Ltd., Shanghai, China) emulsified in complete Freund's adjuvant with mycobacterium (CFA, Sigma-Aldrich, St. Louis, MO, USA) and was immunized at six different locations (footpads, neck, two sides, and tail). Concurrently, a total of 500 ng of pertussis toxin (PTX, Enzo Life Sciences, Farmingdale, NY, USA) was injected intraperitoneally for every mouse as previously described [35].”